EMERYVILLE, Calif., April 17 /PRNewswire/ -- ProGenTech, a life sciences company based in Shanghai, China and Emeryville, CA is please to announce that it has made several executive management appointments to build out its global senior management team.
Dr. Paul Richardson has joined ProGenTech as its Vice President for R&D based in Emeryville, CA. Dr. Richardson will lead the global R&D programs and have accountability for the company's assay development and reagent solutions. Dr. Richardson was previously the head of R&D at the DOE's Joint Genome Institute where for the past ten years he had led the advanced research teams supporting the human genome project as well as the microbial genome initiatives and other model organism programs. Dr. Richardson brings a wealth of life science knowledge to the company.
Dr. Jesus Ching has been appointed the Chief Scientist for ProGenTech and will be based in Emeryville, CA. Dr. Ching was a founder of ProGenTech and has been instrumental in the design and development in the products to date. Dr. Ching will have accountability for the external scientific programs as well as our technical lead on business development activities. Dr. Ching was previously the director of R&D at Cepheid and brings deep knowledge and experience in integrated systems and diagnostic platforms.
Sarah Wenning has joined ProGenTech as its Vice President of US operations, based in Emeryville CA. Ms. Wenning will have accountability for all US programs. She was previously the deputy associate director for operations of Lawrence Livermore National Laboratory's Biosciences Directorate and has held a number of senior management roles within Lawrence Livermore for the past ten years. Sarah brings significant operational expertise to the company.
Dylan Bird has joined ProGenTech as its Director of Business Development, based in Emeryville, CA. Mr. Bird will have accountability for global strategy and business development activities. Prior to joining ProGenTech, Mr. Bird was an investment professional at Bay City Capital, one of the two VC's that were part of the recently announced Series C financing.
David Hu has joined ProGenTech as its Vice President of Engineering, based in Shanghai. Mr Hu will have accountability for all engineering programs and new system development and commercialization. David will work closely with Paul Richardson to define our new product roadmaps. David was the lead Angel investor for ProGenTech and remains a member of the ProGenTech board. David has made a career as an entrepreneur and has successfully started, capitalized and sold several businesses in the consumer electronics field.
Commenting on the new team, Dr Trevor Hawkins, ProGenTech Chairman and CEO said "we have built a first class team that truly understands this market and most importantly our customers. We now have deep experience in life sciences, clinical diagnostics and systems engineering." Steve Yu, ProGenTech President and COO said "with the additional executive members coming on board, ProGenTech is now well positioned to penetrate the life science and molecular diagnostic market with our leading technologies"
ProGenTech is a life science company based in Shanghai, Suzhou and Emeryville California.
Established in 2005, the company has 40 employees today. Their first product, the Entura, was launched in Asia in November 2007. Additional information about ProGenTech can be found at http://www.progentech.com.
|SOURCE ProGenTech Limited|
Copyright©2008 PR Newswire.
All rights reserved